The judge overseeing a class action against Qoin cryptocurrency issuer BPS Financial and several related companies has questioned the level of precision required of the pleadings, as the company fights theĀ applicantās bid to amend its case for the fourth time.
A German company and its director have been ordered to pay over $350,000 in damages to the patent holder of a infringing device used to detect āletsā in tennis that was used at the Australian Open for three years.
Qoin cryptocurrency issuer BPS Financial is fighting a class action applicantās bid to amend its case for the fourth time, saying it is trying to bring an “entirely new claim”.
Agricultural giant Nufarm has lost its appeal of a decision giving rival Advanta Seeds extra time to pay a renewal fee for its patent for a hybrid plant cell, after an error by its lawyers caused the renewal to fall through the cracks.
Two home finance companies and their father-son directors have been hit with $150,000 in penalties after a judge found they failed to cooperate with the Australian Financial Complaints Authority in an ASIC enforcement action and subjected AFCA staff to āinappropriate and unprofessional behaviour.ā
Gold Coast āfinfluencerā Tyson Scholz provided illegal financial services by giving tips on his Instagram account and to customers who paid for access to his seminars and āBlack Wolf Pitā chat room, a judge has found.
ASIC has lost a case accusing the Commonwealth Bank of Australia of hitting customers with $55 million in unauthorised fees, with a judge finding that nearly 1 million customers charged the fees should have known that even banks “sometimes make mistakes”.
A judge has ordered timeshare company Ultiqa Lifestyle Promotions to pay a $900,000 penalty for cornering consumers into investing thousands in a timeshare scheme that many could not afford.
The self-declared āwolf traderā of the Gold Coast, Tyson Scholz, has won his bid to exclude ASICās evidence about the meaning of his tweets in its case accusing him of providing unlicensed financial services.
A judge has thrown out competing appeals of a decision finding Pfizer’s patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.